TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Researchers report that the brain enzyme Pla2g2f helped preserve memory and reduce several signs of brain aging in mice when its levels were increased. Its activity also reduced lipid droplet buildup in human microglia in laboratory experiments, but whether this can lead to a safe treatment for people is unknown.
Increasing the brain enzyme Pla2g2f protected aging mice against several changes linked to cognitive decline, including memory impairment, according to a study published in Nature Neuroscience. Researchers also found that raising the enzyme’s activity reduced lipid buildup in human microglia in laboratory experiments, but the findings do not establish a treatment for people.
The research team identified Pla2g2f while studying genes activated in response to synapse loss in the hippocampus, a brain region important for memory. The gene produces a secreted phospholipase enzyme whose role in the brain had not previously been established, the researchers reported. Pla2g2f levels rose in the hippocampus with age and during brain inflammation.
To investigate its effects, the researchers used genetic and viral tools to lower or increase Pla2g2f in the brains of aging mice. Lowering the enzyme worsened several measures, including synapse loss, inflammation, disrupted lipid metabolism and memory impairment. It was also associated with impaired maturation of new brain cells and lipid droplet accumulation in neurons and microglia. Increasing Pla2g2f protected against many of these changes and helped preserve memory.
The researchers said that boosting the enzyme in middle-aged mice, before substantial cognitive decline had developed, changed the course of age-related memory loss. In experiments involving human microglia, increasing Pla2g2f activity reduced lipid droplets and cholesterol esters. These results in cells and mice do not show that the same approach will prevent or treat cognitive decline in humans.
A Potential Route to Brain Resilience
The findings point to a possible protective process in aging brain tissue. Rather than focusing only on damage, the study examined biological factors that may help the brain withstand age-related stress. Pla2g2f’s effects across synapses, inflammation and lipid handling suggest it could influence several processes tied to brain aging.
That breadth makes the enzyme a candidate for further research, not a proven therapy. Aging is a major risk factor for Alzheimer’s disease, but the study does not show that changing Pla2g2f prevents Alzheimer’s or mild cognitive impairment in people. Its relevance for readers is the identification of a potential research target and the need for testing its safety and effectiveness before any clinical use.
brain health supplements for memory
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
How Researchers Identified Pla2g2f
The study was led by Cinzia Vicidomini and senior-authored by Amar Sahay, affiliated with Mass General Brigham’s Department of Psychiatry, the Harvard Stem Cell Institute and the Broad Institute of Harvard and MIT. Their paper, “An aging-sensitive secreted phospholipase confers neuroprotection and cognitive resilience,” was published in Nature Neuroscience.
The team began with hippocampal synapse loss, a feature associated with age-related cognitive decline, and looked for genes activated in response. They then tested Pla2g2f by changing its levels in aging mice and assessed related brain changes and memory. The researchers also examined Pla2g2f activity in human microglia, the brain’s immune cells, focusing on lipid accumulation.
The study addresses one proposed contributor to neuroinflammation: lipid droplets accumulating in microglia. The researchers describe this buildup as associated with reduced ability to clear waste, maintain synapses and support neurons. The work tests a possible protective factor within this biology; it does not establish that lipid droplets alone cause cognitive decline.
“We sought to identify the protective factors that contribute to cognitive resilience during aging.”
— Cinzia Vicidomini and Amar Sahay, the study’s lead and senior authors, in the News-Medical report
As an affiliate, we earn on qualifying purchases.
Human Treatment Remains Unproven
The report does not establish whether increasing Pla2g2f in a living human brain is feasible, safe or effective. The protective effects on memory were tested in mice; the human component concerned microglia in laboratory experiments, not clinical outcomes in patients.
Researchers have not shown that the enzyme prevents or delays Alzheimer’s disease, mild cognitive impairment or other diagnoses in people. The source does not specify a proposed drug, delivery method, dose, treatment schedule or timeline for clinical testing. It also remains unclear which mechanisms account for the enzyme’s effects across the different brain changes measured.
As an affiliate, we earn on qualifying purchases.
Testing Safe Ways to Raise Pla2g2f
The researchers say they are exploring approaches to increase Pla2g2f in the aging brain and in Alzheimer’s disease. Before the idea could be tested as a patient therapy, further work would need to assess how the enzyme can be raised, whether the effects hold up in additional studies, and what safety risks may arise.
No clinical trial or patient treatment timeline was provided in the source material. For now, the reported results support continued preclinical research into Pla2g2f as a possible contributor to cognitive resilience, rather than a change in care for people experiencing memory problems.
neuroprotective enzyme supplements
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What is Pla2g2f?
Pla2g2f is a gene that produces a secreted phospholipase enzyme. The study investigated its previously unknown role in the brain and found that its levels rose in the hippocampus during aging and inflammation.
Did the enzyme prevent memory decline in people?
No. The reported memory findings came from experiments in aging mice. Human microglia experiments measured lipid buildup, not memory or clinical outcomes.
Does the study show that Pla2g2f prevents Alzheimer’s disease?
No. The researchers describe the enzyme as a possible therapeutic research target. The study does not establish that raising Pla2g2f prevents or treats Alzheimer’s disease in people.
What happens next?
The authors say they are exploring ways to raise Pla2g2f levels safely in the aging brain. The report gives no clinical trial details or timeline, and further research is needed before a patient treatment can be assessed.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
